Understanding Ventricular Pressure-Volume Catheter Calibrations and Experimental Design

Sponsored by:

Date:

November 17, 2015

No items found.

An in-depth exploration of ventricular pressure-volume catheter calibration parameters, considerations for experimental design and their effects on your pressure-volume data.

Cardiovascular researchers interested in acquiring baseline and load-independent ventricular pressure-volume data face a multitude of questions regarding technology, calibration and experimental design. Focusing on results and keeping the end in mind is often where the best answers lie.

In this webinar sponsored by ADInstruments, Dr. Dimitrios "Jim" Georgakopoulos ‚Äî an expert in the theory, history and application of ventricular pressure-volume science ‚Äî discusses conductance-based pressure-volume technology, the theory and importance behind resistivity and parallel volume calibration factors, how experimental conditions can (and should) influence your approach and the significance of proper calibration in acquiring quality results.

Presenters

Dimitrios “Jim” Georgakopoulos

Sunshine Heart

Chief Scientific Officer

Dr. Georgakopoulos started his PV loop research in 1994 alongside David Kass. Over the next 10 years together they worked on many “firsts” relating to PV Loop science, including development of the first systems and methodologies for obtaining PV loops in the mouse.

ADInstruments

Established in 1988, ADInstruments develops high performance digital data acquisition and analysis solutions for biomedical research and life science education.

Topics

Disease Models

Pharmacology

Understanding Ventricular Pressure-Volume Catheter Calibrations and Experimental Design

Presenters

Dimitrios “Jim” Georgakopoulos

Sponsor

ADInstruments

Topics

Watch Now

Related Content

Engineering Neuromodulation for Cardiovascular Instability

Advancing the Manufacture of Mesenchymal Stromal Cells and Derived Extracellular Vesicles in Stirred-Tank Bioreactors Through Enhanced Bioprocess Control

From Clinical Data to Actionable Assets for Pharmaceutical R&D

Improving Preclinical Decision-Making in Obesity and CKD with Translational In Vivo Phenotyping

Advancing the Manufacture of Mesenchymal Stromal Cells and Derived Extracellular Vesicles in Stirred-Tank Bioreactors Through Enhanced Bioprocess Control

Functional Ultrasound Demonstration and Live Q&A: Iconeus One, a Pioneer in Real-Time Whole-Brain Imaging

Precision in Human Biological Samples: Leveraging Regulatory Rigor and Deep Data for Advanced Disease Research

Detecting Early Synaptic Failure in Prion Disease Using Organoid Models

Bridging Mouse Models and Human Inflammatory Bowel Disease: in vivo Pharmacology, Histology and Biomarkers

Skeletal Muscle Circadian Clocks: Keeping Time for Systemic Health

Screening the Unscreenable: Expanding the Reach of Drug Discovery

High-Throughput-qPCR and Transcriptomics: Powering the Next Generation of Drug Discovery

From Clinical Data to Actionable Assets for Pharmaceutical R&D

Strategies to Optimize Commercialization of Oncology Treatments for Younger Adults

Patient Data: Opportunities for Rare Diseases, Cell and Gene Therapies, and Oncology

Trials and tribulations of drug development

Webinar Series: Early patient preferences for patient-focused drug development

Using AI and Technology to Streamline Post-Stroke Patient Journeys to Cardiology

Looking Beyond Survival Data: Understanding the Value of Non-OS Endpoints in Oncology Reimbursement Decision-Making

Cutting Edge Conversations: Fighting Neurodegenerative Diseases

Cutting Edge Conversations: Discovering New Innovations in Oncology

Cutting Edge Conversations: Addressing COVID-19 During Uncertainty

Cutting Edge Conversations: Finding Solutions to the Obesity Epidemic

Translational Success in Inflammasome Drug Discovery: How Advanced Models and Integrated Assays Can Reduce Attrition

How to Avoid Expensive Redesign Cycles in Antibody Discovery

Recent Advances in Crystalline Polymorphism Research in Drug Development

Engineering Neuromodulation for Cardiovascular Instability

Improving Confidence in Thyroid Hormone Disruption Assessment Using a Novel Human-Relevant In Vitro Model

Accelerating Antibody Discovery: Integrating Microfluidics, HT Expression, and Early Developability Platform

Beyond Exposure: Integrating PK/PD for Translational Predictive Power

Illuminating the Brain: Advances in Neurobiology

Fulfilling the Gap: Innovative Critical Reagents for Non-Human Primate Preclinical Studies

Advancing ADC Development: Leveraging AI and Translational Preclinical Models to Improve Clinical Predictability

Scaling AAV9 Manufacturing: A Blueprint for Clinical-Grade Gene Therapy Production

Human iPSC-Derived Sensory Neurons for Functional Sensory Biology and Pharmacology Research

From Biopsy to Better Decisions: Patient-Derived Organoids Predict Treatment Response in Metastatic Colorectal Cancer

Accelerating Conjugation Process Development for Next-Generation ADCs: Key Considerations and Platform Strategies

Epigenomics at 360 in Liquid Biopsy: Approaches and Case Studies for Biomarker Discovery and Drug Development

The Sound of Science: Mapping the Tumor Microenvironment for Advanced Therapeutic Strategies

Next-Generation TCR-Like Antibodies With Improved Specificity Profiles

ADC Payload-Linker CMC Process Development Strategy

Opening a New Window: Stable Long-Term Imaging of Dura Mater-Transplanted Pancreatic Islets in Awake Mice

De-Risking Immunotherapy Targets with Next-Gen HLA Discovery Platforms

The Expert Approach to Preclinical Indirect Calorimetry Experiments

Photoreceptor Cell Therapy to Treat Advanced Retinal Degeneration

Clinical Applications of Optical Cerebral Blood Flow Imaging

ADCs on The Horizon: The Performance and Prospect of Cell Line Development Platform ‚Äî AmigoCHO

Selectivity Profiling: Unbiased Analysis of Compound Selectivity in Drug Discovery

Building New Approach Methodologies for Angiogenesis and Vascularized Models

Using ALS Patient-Derived Motor Neurons to Study TDP-43 Mislocalization

Gene-Agnostic Gene Therapy to Preserve Vision

Vevo Ask The Experts: Oncology Imaging

hiPSC-Cardiomyocyte Platforms Enabling Comprehensive Cardiac Toxicity and Drug Efficacy Evaluation

Transcranial Focused Ultrasound Neuromodulation of the Default Mode Network in the Treatment of Depression and Promotion of Wellness

Protein-Protein Interaction (PPI) Landscape - Sequence-to-Affinity Heatmaps for High-Throughput Antibody Optimization

Human Biological Samples in Research: Quality, Compliance, and Clinical Relevance

FUJIFILM VisualSonics' Advanced Cardio Symposium

Combination Therapy for Glioblastoma: A Personalized, AI-Driven Approach

In Vivo panCAR Therapy Using Circular RNA for the Treatment of Autoimmune Disease

Noninvasive Imaging of Liver Disease by MRI and Photoacoustic Ultrasound

Recent Advances in Diagnosis of Autonomic Syncope

From Single Domain to Single B: Leveraging Biointron's Expertise for Antibody Discovery Success

Beyond Checkpoints: Strategic Use of CDX Models in Emerging IO Therapies

Non CYP Mediated Metabolism Pathways and In Vitro Evaluation Strategies

Uniting biology and digital drug discovery to identify new therapeutic opportunities in neurodegeneration

Enhance Your Tissue Processing Efficiency with the STEMprep Tissue Dissociator

Reprogramming Mouse Fibroblasts Into Induced Cardiomyocytes: Age-Related, Metabolic, and Epigenetic Barriers

Novel Applications of the Cellular Thermal Shift Assay (CETSA) Provide New Insights for Drug Discovery

Vaccine-Boosting CAR T Cells Against Solid Tumors

Exploring the iPSC-Derived Neuronal-Glia Co-culture System: A Powerful Drug Discovery Platform for Studying Neurodegenerative Diseases

Integrating Regulatory Guidance and Sustainable Skin Procurement for Consistent Execution of In Vitro Permeation Testing

Redox Regulation of Skeletal Muscle: A Journey from Liverpool to the International Space Station